Skye Bioscience, Inc.
SKYE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$26,567 | -$37,645 | -$19,482 | -$8,522 |
| Dep. & Amort. | $299 | $124 | $115 | $34 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $8,317 | $988 | $629 | $869 |
| Change in WC | -$2,629 | -$469 | -$762 | $647 |
| Other Non-Cash | -$4,658 | $23,050 | $6,755 | $497 |
| Operating Cash Flow | -$25,237 | -$13,952 | -$12,744 | -$6,475 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,604 | -$13 | -$28 | -$91 |
| Net Acquisitions | $0 | $0 | $5,309 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $1,358 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $6,609 | -$66 | $0 |
| Investing Cash Flow | -$246 | $6,596 | $5,214 | -$91 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $4,714 | -$211 | $0 |
| Stock Issued | $83,557 | $11,735 | $2 | $6,063 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $6 | -$6 | $0 | $7,017 |
| Financing Cash Flow | $83,562 | $16,443 | -$209 | $13,079 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $58,079 | $9,088 | -$7,738 | $6,514 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $10,337 | $1,249 | $8,988 | $2,474 |
| End Cash | $68,416 | $10,337 | $1,249 | $8,988 |
| Free Cash Flow | -$26,842 | -$13,965 | -$12,772 | -$6,566 |